Strategies to Improve Iodine Status in Early Pregnancy

February 6, 2024 updated by: Jayne Woodside, PhD, Queen's University, Belfast
This study aims to investigate the benefit of increased intake of cows' milk during pregnancy on iodine status.

Study Overview

Detailed Description

Women of child bearing age, and those who are currently pregnant, have been found to be iodine deficient in the United Kingdom (UK). Dairy products are an essential source of iodine in the UK as iodised salt is not widely available. This study will ask women in the intervention group to drink approximately one pint of milk a day for 12 weeks during pregnancy.

Study Type

Interventional

Enrollment (Actual)

119

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Belfast, United Kingdom, BT12 6BA
        • Royal Jubilee Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • women at 6-16 weeks pregnant
  • women receiving antenatal care within Belfast Health and Social Care Trust

Exclusion Criteria:

  • women with known thyroid disease currently taking thyroid medication
  • women with type one diabetes
  • women under 18 years of age
  • those unable to provide informed consent
  • women with abnormal thyroid function tests at booking appointment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Iodine Control
Participants taking an iodine-containing multivitamin or supplement and randomly allocated not to receive milk supply.
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
Active Comparator: No Iodine Control
Participants not taking an iodine-containing multivitamin or supplement and randomly allocated not to receive milk supply.
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
Experimental: Iodine Intervention
Participants taking an iodine-containing multivitamin or supplement and randomly allocated to receive milk supply.
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
Intervention groups will receive a free 12 week supply of cows' milk equating to a pint a day for study participants. Milk is provided by Lakeland dairies.
Experimental: No Iodine Intervention
Participants not taking an iodine-containing multivitamin or supplement and randomly allocated to receive milk supply.
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
Intervention groups will receive a free 12 week supply of cows' milk equating to a pint a day for study participants. Milk is provided by Lakeland dairies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary iodine concentration
Time Frame: 18 months
Proportion of the maternal cohort who achieve WHO urinary iodine concentration(UIC) of >=150 micrograms/litre on early morning spot urinary sampling at 12 weeks post intervention.
18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Iodine knowledge
Time Frame: 24 months
Knowledge regarding iodine intake in the diet in pregnancy and into postpartum assessed using an iodine knowledge questionnaire that will be completed by participants at the beginning and the end of the study period.
24 months
Iodine intake
Time Frame: 24 months
Intake of iodine rich foods at 29 weeks and postpartum in those who breastfeed will be assessed using four day food diaries at the beginning and end of the study, and validated iodine-specific food frequency questionnaires at the beginning of the study, at the end of the intervention period, six weeks after the end of the intervention period and at the end of the study.
24 months
Offspring
Time Frame: 24 months.
Proportion of offspring with adequate UIC at 6-12 weeks old.
24 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karen Mullan, MD, Belfast Health and Social Care Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2021

Primary Completion (Actual)

July 21, 2023

Study Completion (Actual)

August 3, 2023

Study Registration Dates

First Submitted

November 25, 2021

First Submitted That Met QC Criteria

December 9, 2021

First Posted (Actual)

December 28, 2021

Study Record Updates

Last Update Posted (Estimated)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • B20/32
  • EAT/5578/19 (Other Grant/Funding Number: Public Health Agency R&D fellowship)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Subscribe